Balmain Pharmaceuticals, Inc.

Developing a potential cure for HBV, which has a compelling US market opportunity (for curative drugs) and is also a major global health concern.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Founded April 2019
  • Employees 2
  • Incorporation Type C-corp

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free